SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS), a specialty pharmaceutical company, today reported preliminary record total revenues and net product sales for the year ended December 31, 2008. Total revenues for the year ended December 31, 2008 are expected to be approximately $130.2 million, up approximately 38% from total revenues of $94.4 million for the year ended December 31, 2007. Net product sales for 2008 are expected to be approximately $101.2 million, up approximately 27% from net product sales of $79.4 million for 2007.
